Lewis-Hall Freda C
SEC CIK 1437909 · EDGAR
Most active insiders at CDT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Taylor Mark Andrew | 10% | — | $2.95M |
| 2 | Prospect Capital Securities Ltd | 10% | — | — |
| 3 | Regan Andrew | CEO, Dir | — | — |
| 4 | Corvus Capital Ltd. | 10% | — | — |
| 5 | Farley Chele Chiavacci | Dir | — | — |
Lewis-Hall Freda C made no open-market trades at CDT in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-08-26 | 2025-08-12 | CDT | CDT Equity Inc. | Lewis-Hall Freda C | Dir | A - Grant | $0.00 | +35.0K | 38.5K | +1,010% | $0 |
| 2025-04-01 | 2025-03-30 | CDT | CDT Equity Inc. | Lewis-Hall Freda C | Dir | A - Grant | $0.89 | +47.6K | 52.0K | +1,087% | +$42.4K | |
| 2024-11-20 | 2024-11-18 | CDT | CDT Equity Inc. | Lewis-Hall Freda C | Dir | A - Grant | $0.09 | +438.0K | 438.0K | New | +$39.4K | |
| 2024-03-28 | 2024-03-26 | PYXS | Pyxis Oncology, Inc. | Lewis-Hall Freda C | Dir | A - Grant | $0.00 | +35.2K | 241.4K | +17% | $0 | |
| 2023-03-28 | 2023-03-24 | PYXS | Pyxis Oncology, Inc. | Lewis-Hall Freda C | Dir | A - Grant | $0.00 | +139.4K | 206.2K | +209% | $0 | |
| 2022-04-04 | 2022-03-31 | PYXS | Pyxis Oncology, Inc. | Lewis-Hall Freda C | Dir | A - Grant | $0.00 | +66.8K | 66.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations